ATHA Earnings
Athira Pharma Inc
$
0.385
- Overview
- Forecast
- Valuation
- Earnings
Earning Analysis
Welcome to our in-depth analysis of Athira Pharma Inc(ATHA) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of Athira Pharma Inc earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.
Earnings Forecast
Revenue
EPS
Currency:
Actual
Estimate
Surprise Analysis
| FY2025Q2 | 2025-08-07 | - | -0.18 | - | - | - | - | - | -2.37 | +1.53 |
| FY2024Q4 | 2025-02-27 | After Hours | -0.23 | -0.39 | -69.57 | - | 0.00 | - | -2.82 | -17.13 |
| FY2024Q2 | 2024-08-01 | - | -0.75 | -0.70 | +6.67 | - | - | - | +1.88 | -2.82 |
| FY2024Q1 | 2024-05-15 | - | -0.80 | -0.69 | +13.75 | - | - | - | +0.45 | +15.45 |
| FY2023Q4 | 2024-02-22 | - | -0.96 | -0.71 | +26.04 | - | - | - | +6.22 | +7.30 |
| FY2023Q2 | 2023-08-10 | - | -0.81 | -0.78 | +3.70 | - | - | - | +5.21 | -7.99 |
| - | 2023-05-11 | - | -0.66 | -0.73 | -10.61 | - | - | - | -2.96 | -9.21 |
| - | 2023-03-23 | - | -0.70 | -0.79 | -12.86 | - | - | - | -3.61 | -4.82 |
| - | 2022-11-10 | - | -0.67 | -0.53 | +20.90 | - | - | - | +7.97 | +11.59 |
| - | 2022-08-15 | - | -0.66 | -0.65 | +1.52 | - | - | - | - | -5.13 |
ATHA Earnings Analysis
Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, Athira Pharma Inc reported performance for FY2025Q2, announced on 2025-08-07. The company achieved an EPS of , compared to analyst estimates of -0.18 by % . Revenue for the quarter reached 0.00 compared to expectations of 0.00 by % .
The stock price reacted with a -2.37% one-day change and a 1.53% five-day change following the earnings release. These movements reflect market reaction in Athira Pharma Inc growth trajectory and strategic initiatives.
ATHA Earnings Forecast
Looking ahead, Athira Pharma Inc(ATHA) remains a focal point for investors seeking growth opportunities. Analyst forecasts for project quarter revenue of and an EPS of .
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for have been Go Up by 37.43%, while EPS estimates have been No Change by %. For the upcoming , revenue estimates have been adjusted No Change by % . These revisions correlate with a % change in stock price over the same period, suggesting potential buying opportunities for investors who believe in Athira Pharma Inc long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
Estimate Revision
The chart shows the correlation between ATHA's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Stock Price
Go Up
+37.43%
In Past 3 Month
1Y
3Y
5Y
Fiscal Period
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-:0
--
EPS Estimate-:0
—
Stock Price0.38
ATHA Revenue and EPS Performance: A Historical Perspective
Athira Pharma Inc revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2025Q2 (2025-08-07,):
EPS: (Actual) vs.-0.18 (Estimate) (%)
Revenue: 0.00 (Actual) vs. 0.00 (Estimate) (%)
Price Reaction: -2.37%(1-Day), 1.53%(5-Day)
FY2024Q4 (2025-02-27,After Hours):
EPS: -0.39 (Actual) vs.-0.23 (Estimate) (-69.57%)
Revenue: 0.00 (Actual) vs. 0.00 (Estimate) (%)
Price Reaction: -2.82%(1-Day), -17.13%(5-Day)
FY2024Q2 (2024-08-01,):
EPS: -0.70 (Actual) vs.-0.75 (Estimate) (6.67%)
Revenue: 0.00 (Actual) vs. 0.00 (Estimate) (%)
Price Reaction: 1.88%(1-Day), -2.82%(5-Day)
Earnings Reaction
The chart below shows how ATHA performed 10 days before and after its earnings report, based on data from the past quarters. Typically, ATHA sees a -0.25% change in stock price 10 days leading up to the earnings, and a -4.76% change 10 days following the report. On the earnings day itself, the stock moves by +0.91%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in JUN/2025, the stock changed 5.95% on the day following the earnings release and then changed by 4.00% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Transcript Summary
No Data
People Also Watch
CCTG
CCSC Technology International Holdings Ltd
1.070
USD
0.00%
SDOT
Sadot Group Inc
0.871
USD
-1.02%
GYRO
Gyrodyne LLC
10.092
USD
0.00%
COCP
Cocrystal Pharma Inc
1.650
USD
0.00%
COSM
Cosmos Health Inc
0.832
USD
+4.52%
SMSI
Smith Micro Software Inc
0.691
USD
+1.17%
ABTS
Abits Group Inc
4.029
USD
0.00%
MIRA
Mira Pharmaceuticals Inc
1.440
USD
-2.04%
BSGM
BioSig Technologies Inc
4.610
USD
-1.28%
ATER
Aterian Inc
1.285
USD
-1.15%
FAQ
What were the key highlights of ATHA’s latest earnings report for FY2025Q2?
ATHA reported its FY2025Q2 earnings on 2025-08-07, showcasing a revenue of 0.00 against an estimate of 0.00, resulting in a 0% surprise. The EPS was 0, surpassing the expected -0.18 by 0% . The stock experienced a -2.37% price change on the earnings day and a 1.53% change over the next five days, reflecting market reactions to the results.
How did ATHA’s stock price react after the FY2025Q2 earnings release?
What are the revenue and EPS estimates for ATHA for undefined?
How does ATHA’s stock price correlate with earnings forecast revisions?
What should investors expect from ATHA’s next earnings report?